HUP9903375A2 - Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények - Google Patents
Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítményekInfo
- Publication number
- HUP9903375A2 HUP9903375A2 HU9903375A HUP9903375A HUP9903375A2 HU P9903375 A2 HUP9903375 A2 HU P9903375A2 HU 9903375 A HU9903375 A HU 9903375A HU P9903375 A HUP9903375 A HU P9903375A HU P9903375 A2 HUP9903375 A2 HU P9903375A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- synergistic pharmaceutical
- containing olanzapine
- analgetic
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005017 olanzapine Drugs 0.000 title abstract 2
- 230000000202 analgesic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Abstract
A szabadalőm tárgya gyógyszerkészítmény, amely (I) képletű őlanzapintvagy gyógyászatilag elfőgadható sóját, és egy vagy többfájdalőmcsillapító hatóanyagőt tartalmaz. A találmány szerintikészítmény szinergista hatású. ŕ
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9903375A HUP9903375A3 (en) | 1997-03-24 | 1997-03-24 | Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9903375A HUP9903375A3 (en) | 1997-03-24 | 1997-03-24 | Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9903375A2 true HUP9903375A2 (hu) | 2000-02-28 |
HUP9903375A3 HUP9903375A3 (en) | 2000-04-28 |
Family
ID=89999557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9903375A HUP9903375A3 (en) | 1997-03-24 | 1997-03-24 | Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP9903375A3 (hu) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9707184B2 (en) | 2014-07-17 | 2017-07-18 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US10792254B2 (en) | 2013-12-17 | 2020-10-06 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10959958B2 (en) | 2014-10-20 | 2021-03-30 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
-
1997
- 1997-03-24 HU HU9903375A patent/HUP9903375A3/hu unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US10639281B2 (en) | 2013-08-12 | 2020-05-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10792254B2 (en) | 2013-12-17 | 2020-10-06 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9707184B2 (en) | 2014-07-17 | 2017-07-18 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
US10959958B2 (en) | 2014-10-20 | 2021-03-30 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
Also Published As
Publication number | Publication date |
---|---|
HUP9903375A3 (en) | 2000-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2424B1 (en) | Pharmaceutical composition for use in treatment ofdiabetes. | |
IL108007A (en) | USE OF AN INTERFERON-GAMMA (IFN-gamma) INHIBITOR IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | |
IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
HUT75648A (en) | 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and pharmaceutical compositions containing them | |
HUP9900605A3 (en) | Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them | |
PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
IL133784A (en) | Dolastatin 15 derivatives, pharmaceutical compositions comprising them and their use in medicaments for treating cancer | |
IL103303A (en) | Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain | |
MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
AU9018898A (en) | Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments | |
HUP9802795A3 (en) | Pharmaceutical compositions containing beta-adrenergic agent and anorectic agent for the treatment of corpulence | |
HUP9603607A3 (en) | Use of triazolidine derivatives for the preparation of pharmaceutical compositions for the treatment and prophylaxis of osteoporosis | |
EP0683668A4 (en) | PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION. | |
HUP0102025A3 (en) | Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use | |
IL116539A0 (en) | Compositions for transdermal delivery of acid-labile drugs | |
HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
EG23781A (en) | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation | |
HUP9903684A3 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating depression | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
BG106548A (en) | Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog | |
HUP9903375A2 (hu) | Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
HU9400290D0 (en) | Pharmaceutical composition for preventing and treating retinal dieases | |
NZ268110A (en) | Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage |